Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Intrusion Inc., the most common co-covered peer. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline.
Last mentioned: Mar 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Intrusion Inc., the most common co-covered peer. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.8 for that window. We currently track 1 Healthcare story that mention OviTex, all published on March 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 29 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering OviTex. Shared-story counts are live from our verified record — not editorial picks.
TELA Bio and Intrusion Inc. reported their Q4 and full-year 2025 financial results, highlighting growth in soft tissue reconstruction and advanced cybersecurity solutions. These reports, alongside a leadership transition at Reed's Inc., underscore the evolving landscape of medical technology and data protection in the healthcare sector.
Source: manilatimes.net · finanznachrichten.de
OviTex is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
